1. THE ELDERLY PROJECT BY THE FONDAZIONE ITALIANA LINFOMI: A PROSPECTIVE COMPREHENSIVE GERIATRIC ASSESSMENT (CGA) OF 1353 ELDERLY PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019) Authors: Spina, M.; Merli, F.; Puccini, B.; Cavallo, F.; Cabras, M.G.; Fabbri, A.; Angrilli, F.; Zilioli, V.R.; Marino, D.; Balzarotti, M.; Ladetto, M.; Cox, M.C.; Petrucci, L.; Arcari, A.; Gini, G.; Chiappella, A.; Hohaus, S.; Musuraca, G.; Merli, M.; Sartori, R. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R‐CVP WITH R‐CHOP AND R‐FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY. (June 2017) Authors: Luminari, S.; Tarantino, V.; Anastasia, A.; Boccomini, C.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Ferrari, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; Gaidano, G.; Stelitano, C.; Bertoldero, G.; Cascavilla, N.; Salvi, F.; Ferreri, A.J.; Vallisa, D.; Balzarotti, M.; Cox, M.C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL. (17th June 2021) Authors: Martelli, M.; Zucca, E.; Botto, B.; Kryachok, I.; Ceriani, L.; Balzarotti, M.; Tucci, A.; Cabras, M. G.; Zilioli, V. R.; Rusconi, C.; Angrilli, F.; Arcaini, L.; Iwanicka, A. Dabrowska; Ferreri, Andrés J.M.; Merli, F.; Zhao, W.; Hodgson, D.; Ionescu, C.; Fosså, A.; Cwynarski, K. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PHASE II TRIAL OF RITUXIMAB PLUS CHLORAMBUCIL FOLLOWED BY A 2‐YEAR SUBCUTANEOUS RITUXIMAB MAINTENANCE IN MALT LYMPHOMA PATIENTS (IELSG38). (17th June 2021) Authors: Pirosa, M. C.; Orsucci, L.; Feugier, P.; Tani, M.; Ghesquieres, Hervé; Musuraca, G.; Baldini, L.; Merli, F.; De Renzis, B.; Gyan, E.; Gini, G.; Marino, D.; Gressin, R.; Morschhauser, F.; Palombi, F.; Cavallo, F.; Conconi, A.; Le Gouill, S.; Tilly, Hervé; Zanni, M. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL. (June 2017) Authors: Luminari, S.; Marcheselli, L.; Manni, M.; Anastasia, A.; Vitolo, U.; Chiarenza, A.; Rigacci, L.; Angelucci, E.; Fama, A.; Pulsoni, A.; Rattotti, S.; Angrilli, F.; Gaidano, G.; Stelitano, C.; Bertoldero, G.; Cascavilla, N.; Salvi, F.; Ferreri, A.J.; Tarantino, V.; Bellei, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. IMPROVED SURVIVAL OUTCOMES FOR PATIENTS WITH EXTRA‐NODAL NK/T LYMPHOMA: DATA FROM 140 PATIENTS PROSPECTIVELY REGISTERED IN THE INTERNATIONAL T‐CELL PROJECT. (June 2017) Authors: Fox, C.P.; Bellei, M.; Manni, M.; Kim, S.J.; Ko, Y.H.; Shustov, A.R.; Cabrera, M.E.; Chiattone, C.S.; Horwitz, S.M.; Spina, M.; Advani, R.H.; Angrilli, F.; De Souza, C.A.; Dlouhy, I.; Fernandez‐Alvarez, R.; Gabús, R.; Hitz, F.; Laszlo, D.; Montoto, S.; Nagler, A. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗